Stryker stock drops more than 3% after debut of handheld robotic knee replacement device

Traders Union
All News
Financial News
Stryker drops 3.37% today on news

Highlights

Stryker has launched Mako RPS, a handheld robotic system for total knee replacements, expanding its robotics portfolio.
The new device integrates with the Triathlon Total Knee System and emphasizes real-time intraoperative planning for surgeons adopting robotic technology.
Despite recent downside volatility, technical signals indicate mixed momentum with support at $305.25 and a high likelihood of sideways or upward trading near $334.87.

Orthopaedic expansion drives product innovation amid heavy selling response

Stryker Corporation announced the full U.S. commercial launch of Mako RPS, a new handheld robotic system for total knee replacement procedures. The device expands the Mako surgery platform and adds Mako Handheld Robotics to Stryker's portfolio for orthopaedic applications. The system integrates with the Triathlon Total Knee System and features intraoperative planning with real-time adjustments, allowing easier adoption for surgeons interested in robotic technology, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, sees a mismatch between Stryker’s technical structure and its latest product news. He points out the stock is trading above short-term averages but remains pressured below its 200-day trend. Despite the innovative Mako RPS launch, sellers continue to dominate. Momentum indicators are sending mixed signals and volatility remains high. "Until Stryker breaks above $328.58 or reclaims its 200-day moving average, I see limited upside and heightened risk of further downside pressure."

Viktoras Karapetjanc, expert at Traders Union, believes Stryker’s Mako RPS launch marks a meaningful step in the medical robotics field. He notes positive structural signals above short- and medium-term averages, supported by clear institutional interest. Macro environment and robust product innovation suggest room for a sustained upward move, with limited downside risk near $305.25. "New technology adoption and resilient fundamentals mean the bullish structure remains intact — I expect further growth if price stabilizes above key resistance."

Parshwa Turakhiya, analyst, sees a short-term tug of war in Stryker’s price action after the robotic system launch. Sentiment briefly surged on the news, but sharp intraday selling reversed momentum. Technicals signal a sideways opportunity between $305.25 and $334.87, with setups near support for risk-managed trades. "If buyers defend the $319.97 zone, I see potential for quick rebounds — but staying nimble is key given recent volatility."

Short-term strength contrasts with overbought signals and intraday decline

Stryker is trading above its 20-day and 50-day moving averages at $319.97 and $310.55, respectively, but remains below the 200-day moving average at $345.32. This structure points to short- and medium-term buying interest, with lingering longer-term selling pressure as the 50- and 200-day averages remain bearishly aligned. Immediate support is located at the 20-day moving average ($319.97), with resistance at today's high of $328.58. The Ichimoku Kijun at $317.67 also provides nearby support. Momentum indicators tell a mixed story: the MACD is showing strong buy signals, while the ADX remains neutral, indicating limited directional conviction. The RSI, Stochastic RSI, and CCI all signal buy or strong buy, suggesting mild overbought conditions. Bull/Bear Power is showing intraday momentum dominated by buyers with an 'overbought' reading. Today, the stock declined by $11.15, or 3.37%, after a downside gap of about $4.49 (1.36%). The price is holding near the day’s low, and intraday volatility amplitude sits at 3.06%. This implies significant seller pressure after the open, in contrast with the preceding overbought momentum signals.

Earlier, analysts noted that Stryker faced ongoing selling pressure and investor caution following its recent cybersecurity incident and acquisition activity. The launch of Mako Robotic Power System adds a growth catalyst to the narrative, and with technical signals turning mixed but an 80% probability of upside action, investors should monitor whether Stryker can retake resistance at $328.58 to confirm a bullish reversal.

Source of Data: SYK Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.